Cargando…

Combination of acid β-glucosidase mutation and Saposin C deficiency in mice reveals Gba1 mutation dependent and tissue-specific disease phenotype

Gaucher disease is caused by mutations in GBA1 encoding acid β-glucosidase (GCase). Saposin C enhances GCase activity and protects GCase from intracellular proteolysis. Structure simulations indicated that the mutant GCases, N370S (0 S), V394L (4L) and D409V(9V)/H(9H), had altered function. To inves...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liou, Benjamin, Zhang, Wujuan, Fannin, Venette, Quinn, Brian, Ran, Huimin, Xu, Kui, Setchell, Kenneth D. R., Witte, David, Grabowski, Gregory A., Sun, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447580/ https://www.ncbi.nlm.nih.gov/pubmed/30944381 http://dx.doi.org/10.1038/s41598-019-41914-7

Ejemplares similares

PGRN deficiency exacerbates, whereas a brain penetrant PGRN derivative protects, GBA1 mutation-associated pathologies and diseases
por: Zhao, Xiangli, et al.
Publicado: (2022)

Substrate Compositional Variation with Tissue/Region and Gba1 Mutations in Mouse Models–Implications for Gaucher Disease
por: Sun, Ying, et al.
Publicado: (2013)

Specific saposin C deficiency: CNS impairment and acid β-glucosidase effects in the mouse
por: Sun, Ying, et al.
Publicado: (2010)

Substrate Reduction Therapy Reverses Mitochondrial, mTOR, and Autophagy Alterations in a Cell Model of Gaucher Disease
por: Peng, Yanyan, et al.
Publicado: (2021)

Neurological deficits and glycosphingolipid accumulation in saposin B deficient mice
por: Sun, Ying, et al.
Publicado: (2008)

Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits
por: Sun, Ying, et al.
Publicado: (2010)

Isofagomine In Vivo Effects in a Neuronopathic Gaucher Disease Mouse
por: Sun, Ying, et al.
Publicado: (2011)

In Vivo and Ex Vivo Evaluation of L-Type Calcium Channel Blockers on Acid β-Glucosidase in Gaucher Disease Mouse Models
por: Sun, Ying, et al.
Publicado: (2009)

Properties of Neurons Derived from Induced Pluripotent Stem Cells of Gaucher Disease Type 2 Patient Fibroblasts: Potential Role in Neuropathology
por: Sun, Ying, et al.
Publicado: (2015)

α-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism
por: Yun, Seung Pil, et al.
Publicado: (2018)

A Guided Tour of the Structural Biology of Gaucher Disease: Acid-β-Glucosidase and Saposin C
por: Lieberman, Raquel L.
Publicado: (2011)

Gaucher disease: clinical phenotypes and refining GBA mutational spectrum in Thai patients
por: Phetthong, Tim, et al.
Publicado: (2021)

Progression of Behavioral and CNS Deficits in a Viable Murine Model of Chronic Neuronopathic Gaucher Disease
por: Dai, Mei, et al.
Publicado: (2016)

Systemic enzyme delivery by blood-brain barrier-penetrating SapC-DOPS nanovesicles for treatment of neuronopathic Gaucher disease
por: Sun, Ying, et al.
Publicado: (2020)

Ubiquitous Transgene Expression of the Glucosylceramide-Synthesizing Enzyme Accelerates Glucosylceramide Accumulation and Storage Cells in a Gaucher Disease Mouse Model
por: Barnes, Sonya, et al.
Publicado: (2014)

Accumulation of Glucosylceramide in the Absence of the Beta-Glucosidase GBA2 Alters Cytoskeletal Dynamics
por: Raju, Diana, et al.
Publicado: (2015)

No evidence for substrate accumulation in Parkinson brains with GBA mutations
por: Gegg, Matthew E., et al.
Publicado: (2015)

Structural features of many circular and leaderless bacteriocins are similar to those in saposins and saposin-like peptides
por: Towle, K. M., et al.
Publicado: (2017)

The Consequences of GBA Deficiency in the Autophagy–Lysosome System in Parkinson’s Disease Associated with GBA
por: Pradas, Eddie, et al.
Publicado: (2023)

Prosaposin Deficiency and Saposin B Deficiency (Activator-Deficient Metachromatic Leukodystrophy): Report on Two Patients Detected by Analysis of Urinary Sphingolipids and Carrying Novel PSAP Gene Mutations
por: Kuchař, Ladislav, et al.
Publicado: (2009)

Glucocerebrosidase Mutations and Synucleinopathies. Potential Role of Sterylglucosides and Relevance of Studying Both GBA1 and GBA2 Genes
por: Franco, Rafael, et al.
Publicado: (2018)

GBA2-Encoded β-Glucosidase Activity Is Involved in the Inflammatory Response to Pseudomonas aeruginosa
por: Loberto, Nicoletta, et al.
Publicado: (2014)

A Comparative Study of Human Saposins
por: Garrido-Arandia, María, et al.
Publicado: (2018)

Mitochondrial dysfunction and mitophagy defect triggered by heterozygous GBA mutations
por: Li, Hongyu, et al.
Publicado: (2018)

Mutations in GBA and LRRK2 Are Not Associated with Increased Inflammatory Markers
por: Thaler, Avner, et al.
Publicado: (2021)

Gene Therapy for Parkinson’s Disease Associated with GBA1 Mutations
por: Abeliovich, Asa, et al.
Publicado: (2021)

Comparative Transcriptome Analysis in Monocyte-Derived Macrophages of Asymptomatic GBA Mutation Carriers and Patients with GBA-Associated Parkinson’s Disease
por: Usenko, Tatiana, et al.
Publicado: (2021)

Effect of GBA Mutations on Phenotype of Parkinson's Disease: A Study on Chinese Population and a Meta-Analysis
por: Zhang, Yuan, et al.
Publicado: (2015)

Posterior Cortical Atrophy phenotype in a GBA N370S mutation carrier: a case report
por: Picillo, Marina, et al.
Publicado: (2021)

GBA mutations are associated with Rapid Eye Movement Sleep Behavior Disorder
por: Gan-Or, Ziv, et al.
Publicado: (2015)

Plasma Glucosylsphingosine in GBA1 Mutation Carriers with and without Parkinson's Disease
por: Surface, Matthew, et al.
Publicado: (2021)

Analysis of glucocerebrosidase (GBA) gene mutations in Iranian patients with Gaucher disease
por: MOZAFARI, Hadi, et al.
Publicado: (2021)

Challenges in Rare Diseases Diagnostics: Incontinentia Pigmenti with Heterozygous GBA Mutation
por: Minić, Snežana, et al.
Publicado: (2022)

Genetic Testing for GBA and LRRK2 Mutations: Is it Time for Routine Use?
por: Roopnarain, Karisha, et al.
Publicado: (2023)

Global gene expression profile progression in Gaucher disease mouse models
por: Xu, You-Hai, et al.
Publicado: (2011)

Serum Bile Acid Profiling and Mixed Model Analysis Reveal Biomarkers Associated with Pruritus Reduction in Maralixibat-Treated Patients with BSEP Deficiency
por: Zhao, Xueheng, et al.
Publicado: (2022)

Truncated mutants of beta-glucosidase 2 (GBA2) are localized in the mitochondrial matrix and cause mitochondrial fragmentation
por: Sultana, Saki, et al.
Publicado: (2020)

Cross-talks among GBA mutations, glucocerebrosidase, and α-synuclein in GBA-associated Parkinson’s disease and their targeted therapeutic approaches: a comprehensive review
por: Behl, Tapan, et al.
Publicado: (2021)

A saposin deficiency model in Drosophila: Lysosomal storage, progressive neurodegeneration and sensory physiological decline
por: Hindle, Samantha J., et al.
Publicado: (2017)

Visual short-term memory deficits associated with GBA mutation and Parkinson’s disease
por: Zokaei, Nahid, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_eqcn16efga3fnd0n1vfgoecds4